Chapter 7
The letter arrived on a Tuesday.
It came through the institute’s mail system — interdepartmental, not personal — in a cream-colored envelope with the Buchanan Biopharma Foundation logo embossed in the corner.
I found it in my mailbox at nine-fifteen, between a supply catalog and a notice about the building’s holiday schedule.
It looked like every other piece of foundation correspondence I’d received since becoming a finalist: formal, impersonal, addressed to Dr. Hallie Keating in the foundation’s standard typeface.
I opened it at my desk with a mug of coffee going cold and my laptop open to the draft of the co-authored paper I was supposed to be finishing. The letter was one page.
Dear Dr. Keating,
This letter is to inform you that Liam Buchanan has filed a conflict-of-interest disclosure with the Buchanan Biopharma Foundation and has recused himself from all participation in the Innovator Grant selection process, effective immediately.
Mr. Buchanan has stepped down from the grant selection panel and will not attend any remaining board sessions, interviews, or the final ceremony in any evaluative capacity.
The remaining board members have been notified. This recusal does not affect your candidacy or the grant timeline. All sessions will proceed as scheduled with the reduced panel.
If you have any questions, please contact my office directly.
Sincerely, Priya Nair Program Director, Buchanan Biopharma Foundation
I read it twice. Then I set it down on the desk beside my coffee and stared at it for a while, the way you stare at something that has changed shape while you were looking.
He hadn’t just recused himself from the vote.
He’d told me that at the dinner — the vote recusal, the conversation with Hale, the careful, correct distance.
That had been the version I’d accepted: he wouldn’t influence the final decision, but he’d still be in the room, still present at the sessions, still part of the architecture I had to navigate.
This was different. This was everything. He’d stepped down from the panel entirely. No sessions, no interviews, no ceremony. He had removed himself from the process as completely as a person could without leaving the country.
The recusal cost him. I understood the math even before I let myself think about what it meant.
The Innovator Grant was the foundation’s flagship program, the thing Roland had built from the ground up and handed to Liam as proof that the Buchanan name meant something beyond pharmaceuticals.
Stepping down from the panel wasn’t a bureaucratic adjustment — it was a public statement.
It told the foundation’s board, the finalists, the press, and Roland himself that Liam Buchanan had a personal conflict that made him unfit to evaluate the candidates.
In a world where the Buchanan name was currency, he’d just spent a significant piece of it.
Roland would be furious. I knew this without needing to hear it, the way I knew the periodic table or Fern’s feeding schedule — by absorption, by five years of watching the old man’s face when something threatened the dynasty’s image.
Roland Buchanan had built an empire on the principle that powerful men did not concede, did not withdraw, did not admit to complications that could be managed with better optics.
Liam stepping down from his own foundation’s grant program wasn’t management.
It was admission. And admission, in Roland’s world, was weakness.
I picked up my phone. Put it down. Picked it up again.
I wasn’t going to call him. I wasn’t going to text him.
The letter hadn’t come from him — it had come from Priya, through official channels, which meant he’d instructed the foundation to notify me formally rather than telling me himself.
No personal note. No quiet word at a session.
No leveraging the gesture for emotional credit.
He’d done it and said nothing.
I thought about last Saturday. The hour on the floor.
Fern’s fist around his finger. The look over her head that I’d spent four days trying to forget and failing.
He’d come back the way he’d come the first time — alone, empty-handed, in jeans and a gray sweater.
Kinsey had timed it again. Fern had crawled to him this time, which was new — she’d never crawled toward a stranger before, and watching her move across the play mat with that determined, unsteady lurching and plant herself in his lap had done something to the room that none of us had words for.
He’d held her. She’d grabbed the collar of his sweater and babbled into his chest, and he’d looked at me with the bare helplessness of a man who was holding something precious and had no idea what to do next, and I’d said, “She likes when you hum,” and he’d hummed, low and tuneless, and she’d gone still against him.
Two Saturdays. Two hours of his daughter. And now the letter.
I stood up and walked to the window. The parking lot of the adjacent building was half-empty.
A maintenance worker was sweeping leaves off the sidewalk with the slow, purposeful rhythm of someone who knew the leaves would be back tomorrow and didn’t care.
I watched him for a while and tried to organize what I was feeling into categories I could manage.
Anger was the easy one. It was always there, low and steady, the pilot light I’d been running on for fifteen months.
Anger at him for the affair, anger at myself for caring, anger at the whole machinery of the Buchanan world for existing in a way that made a conflict-of-interest recusal feel like a romantic gesture.
The anger was reliable. It was the floor I stood on.
But underneath the anger, something else.
Something that didn’t have a name yet, or had a name I wasn’t willing to say.
The gesture didn’t fit. That was the problem.
It didn’t fit the version of Liam I’d built to survive on — the one who took what he wanted and managed the consequences, the one who’d inherited his father’s playbook and run it with a smile.
That Liam would have stayed on the panel.
That Liam would have used his position to steer the grant her way, because in his world, helping the people you cared about was what power was for, and the idea that his help might be unwanted or compromising wouldn’t have occurred to him.
This Liam — the one who stepped down, who said nothing, who let a formal letter do the talking — was not that man. And the absence of the man I’d prepared for left me standing in a space I hadn’t mapped.
I went back to my desk. Opened the paper. Stared at the cursor.
At eleven, Theo knocked on my office door.
He was holding a printout of his latest assay batch — the numbers were clean, the pediatric markers tracking even tighter than last week’s run.
I pulled the chair around and we went through the data together, line by line, and for forty-five minutes the world contracted to something I understood completely: the science, the patterns, the evidence building toward a conclusion I could prove.
“This is publication-ready,” I told him. “Start formatting the supplementary materials. I want this in the submission pipeline by the end of the month.”
He nodded, excited in the restrained way that young scientists got excited — the visible effort not to bounce, the scholarly composure he was still growing into. “The November dataset is the strongest we’ve had. If the December samples track the same way—”
“They will. The pattern is consistent across three cohorts now. This isn’t noise.”
“So the grant presentation—”
“Will be the best one in that room.” I said it with a certainty I felt all the way to my bones.
Whatever was happening with Liam, whatever the letter on my desk meant or didn’t mean, the work was real.
The data was real. And I was going to walk into that final presentation and win on the science, not on the name I used to carry.
Theo left. I sat at my desk and let the data high settle, the way it always did — a brief, clean feeling that the world made sense, followed by the return of everything that didn’t.
My phone buzzed. A text from an unknown number. I tensed — but it was Metz, not Liam.
Dr. Keating — Carolyn Metz. Priya shared my contact information with all finalists for the remaining sessions.
I wanted you to know the panel adjustment won’t affect the evaluation framework.
The six of us are fully aligned on criteria.
If anything, the process is cleaner now. Don’t let this become a distraction.
I read it twice. Metz was not a woman who sent casual texts.
Every word was chosen the way she chose her questions at sessions — sharp, deliberate, aimed at something specific.
She was telling me two things: one, that the panel was functional without Liam, and two, that she knew why he’d left and was instructing me not to let it matter.
I typed back: Thank you, Dr. Metz. The work is what matters. I’ll be ready.
A moment later: I know you will.
Three sentences. Two women. No mention of Liam by name or by implication. The clinical efficiency of people who had spent their careers in institutions that punished sentiment.
Rosa appeared in my doorway at noon with two sandwiches from the café and the expression she wore when she was about to deliver an opinion she hadn’t been asked for.
She was forty-two, a mother of three, and she ran my lab with the organized calm of a woman who had managed far more chaotic systems than a biomarker assay.
“You’ve read that letter four times,” she said, handing me a sandwich. “Whatever it says, eat first.”
“It’s a personnel change on the grant panel.”